Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neil Kumar

Sports Medicine Brandon, FL Medical Doctor

NPI 1285920454 CMS profile 57957

560 S Lakewood Dr Ste 101, Brandon, FL 33511

Open in the dashboard

General payments

$73,904

259 records reported · program years 2019–2025

Research payments

$2,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$89,936 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Neil Kumar of Brandon, FL is reported in the CMS Open Payments database as having received $73,904 across 259 general payments and $2,500 in research payments paid to them. Separately, studies naming them as principal investigator received $89,936 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,163 68
2024 General $32,158 55
2024 Research $2,500 1
2023 General $1,943 33
2022 General $5,382 21
2021 General $3,654 19
2020 General $5,516 38
2019 General $2,087 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neil Kumar
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Neil Kumar were reported at $23,163. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Neil Kumar Sports Medicine median Middle half National median
2019 $2,087 $1,176 $199–$4,249 $163
2020 $5,516 $708 $96–$2,890 $114
2021 $3,654 $1,213 $152–$3,994 $132
2022 $5,382 $1,230 $159–$3,998 $149
2023 $1,943 $584 $146–$2,836 $160
2024 $32,158 $628 $163–$3,168 $164
2025 $23,163 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vericel Corporation $45,660 43 payments
  2. Arthrex, Inc. $12,546 40 payments
  3. MVP Orthopedics Inc $4,949 10 payments
  4. Coastal Medical Technologies LLC $2,503 57 payments
  5. Davol Inc. $2,082 2 payments
  6. Miach Orthopaedics, Inc. $1,689 5 payments
  7. Smith+Nephew, Inc. $1,599 36 payments
  8. Stryker Corporation $1,574 40 payments
  9. Linvatec Corporation $240 2 payments
  10. Ossur Americas., Inc $150 1 payment
  11. Other $910 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $22,075 7 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $14,613 7 payments
  3. Food and Beverage $10,651 203 payments
  4. Consulting Fee $9,013 4 payments
  5. Education $7,272 6 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,169 5 payments
  7. Travel and Lodging $5,111 27 payments
Products named General payments · program years 2019–2025
  1. MACI $45,643 42 payments
  2. REUNION $611 17 payments
  3. Bioinductive Implant with Arthroscopic Delivery System - Medium $344 4 payments
  4. TWINFIX $262 2 payments
  5. TRAUMA $254 3 payments
  6. BIOBRACE 23MM $240 2 payments
  7. T2 $181 7 payments
  8. VARIAX $154 2 payments
  9. Unloader One X $150 1 payment
  10. Irrisept $150 1 payment
  11. Other $3,266 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Vericel Corporation $2,500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Orthopedic Surgery: 203

Drug cost

$104

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 11 $104

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$48,991

Of which drugs: $2,460

Medicare patients

96

Average age 72

Services billed

1,443

69 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 43%
Depression 43%
Diabetes 36%
Chronic kidney disease 27%
Osteoporosis 24%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

260 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record